By Adriano Marchese

Koninklijke Philips NV said Tuesday that it has received clearance from the U.S. Food and Drug Administration for its wearable biosensor for confirmed and suspected coronavirus patients.

The Dutch technology company said the solution has already received CE mark, and is currently in use with the first install at the OLVG Hospital--a clinical, referral and training hospital in the Netherlands--to help manage the triage and clinical surveillance of Covid-19 patients.

Write to Adriano Marchese at adriano.marchese@wsj.com

(END) Dow Jones Newswires

May 26, 2020 10:32 ET (14:32 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Koninklijke Philips NV Charts.
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Koninklijke Philips NV Charts.